Impaired sensitivity to thyroid hormones is associated with albuminuria in the euthyroid population: results from NHANES.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101142469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2520-8721 (Electronic) Linking ISSN: 11093099 NLM ISO Abbreviation: Hormones (Athens) Subsets: MEDLINE
    • Publication Information:
      Publication: <2018-> : [Cham] : Springer International Publishing
      Original Publication: Athens, Greece : Hellenic Endocrine Society, [2002]-
    • Subject Terms:
    • Abstract:
      Purpose: The relationship between thyroid hormone sensitivity and albuminuria remains unclear. We aimed to investigate the association between thyroid hormone sensitivity and the risk of albuminuria in a euthyroid population.
      Methods: This cross-sectional study included 7634 euthyroid adults collected from the National Health and Nutrition Examination Survey (NHANES) between 2007 and 2012. Central sensitivity to thyroid hormones was evaluated using the thyroid-stimulating hormone index (TSHI), the thyrotrophic thyroxine resistance index (TT4RI), and the thyroid feedback quantile-based index (TFQI). Peripheral sensitivity to thyroid hormones was measured using the free triiodothyronine/free thyroxine (FT3/FT4) ratio. Furthermore, the independent relationship between sensitivity to thyroid hormones and albuminuria was assessed.
      Results: The proportion of albuminuria increased with a higher interquartile range of TFQI levels (7.31% vs. 7.89% vs. 7.95% vs. 9.89%, P = 0.024). Furthermore, TFQI was found to be independently associated with the risk of albuminuria after adjusting for confounding factors (OR = 1.28, 95% CI 1.01-1.60, P = 0.037). Subgroup analysis revealed a significant relationship between TFQI and albuminuria, especially among individuals over 60.
      Conclusions: In euthyroid subjects, impaired central sensitivity to thyroid hormones is associated with albuminuria. TFQI holds significant potential as an epidemiological tool for quantifying the impact of impaired central sensitivity on the risk of albuminuria.
      (© 2024. The Author(s), under exclusive licence to Hellenic Endocrine Society.)
    • References:
      Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011) 12(1):7–11. https://doi.org/10.1016/j.kisu.2021.11.003. (PMID: 10.1016/j.kisu.2021.11.00335529086)
      Levey AS, Becker C, Inker LA (2015) Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA 313(8):837–846. https://doi.org/10.1001/jama.2015.0602. (PMID: 10.1001/jama.2015.0602257106604410363)
      Wang XL, Lu JM, Pan CY, Tian H, Li CL (2005) A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects. Diabet Med 22(3):332–335. https://doi.org/10.1111/j.1464-5491.2004.01408.x. (PMID: 10.1111/j.1464-5491.2004.01408.x15717883)
      Griffin KA (2017) Hypertensive kidney injury and the progression of chronic kidney disease. Hypertension 70(4):687–694. https://doi.org/10.1161/hypertensionaha.117.08314. (PMID: 10.1161/hypertensionaha.117.0831428760941)
      Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375(9731):2073–2081. https://doi.org/10.1016/s0140-6736(10)60674-5. (PMID: 10.1016/s0140-6736(10)60674-5204834513993088)
      Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, Targher G, Byrne CD, Yuan WJ, Zheng MH (2021) MAFLD and risk of CKD. Metabolism 115154433. https://doi.org/10.1016/j.metabol.2020.154433.
      Wijarnpreecha K, Thongprayoon C, Boonpheng B, Panjawatanan P, Sharma K, Ungprasert P, Pungpapong S, Cheungpasitporn W (2018) Nonalcoholic fatty liver disease and albuminuria: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 30(9):986–994. https://doi.org/10.1097/meg.0000000000001169. (PMID: 10.1097/meg.000000000000116929787418)
      Lambers Heerspink HJ, Gansevoort RT (2015) Albuminuria is an appropriate therapeutic target in patients with CKD: the pro view. Clin J Am Soc Nephrol 10(6):1079–1088. https://doi.org/10.2215/cjn.11511114. (PMID: 10.2215/cjn.11511114258870734455219)
      Reinhardt W, Mülling N, Behrendt S, Benson S, Dolff S, Führer D, Tan S (2021) Association between albuminuria and thyroid function in patients with chronic kidney disease. Endocrine 73(2):367–373. https://doi.org/10.1007/s12020-021-02640-1. (PMID: 10.1007/s12020-021-02640-1335758998263419)
      Du X, Pan B, Li W, Zou Y, Hua X, Huang W, Wan X, Cao C (2017) Albuminuria is an independent risk factor of T4 elevation in chronic kidney disease. Sci Rep 741302. https://doi.org/10.1038/srep41302.
      Yang Z, Duan P, Li W, Nie R, Lou X, Wang L, Wu K, Liu J, Tu P, Lai X (2022) The correlation between thyroid hormone levels and the kidney disease progression risk in patients with type 2 diabetes. Diabetes Metab Syndr Obes 1559–67. https://doi.org/10.2147/dmso.S347862.
      Kwong N, Medici M, Marqusee E, Wassner AJ (2021) Severity of proteinuria is directly associated with risk of hypothyroidism in adults. J Clin Endocrinol Metab 106(2):e757–e762. https://doi.org/10.1210/clinem/dgaa872. (PMID: 10.1210/clinem/dgaa87233245743)
      Gondil VS, Chandrasekaran A, Rastogi A, Yadav AK, Sood A, Ramachandran R, Kumar V, Rathi M, Kohli HS, Jha V, Gupta KL (2021) Proteinuria in severe hypothyroidism: a prospective study. J Clin Endocrinol Metab 106(2):e749–e756. https://doi.org/10.1210/clinem/dgaa871. (PMID: 10.1210/clinem/dgaa87133245744)
      Mariani LH, Berns JS (2012) The renal manifestations of thyroid disease. J Am Soc Nephrol 23(1):22–26. https://doi.org/10.1681/asn.2010070766. (PMID: 10.1681/asn.201007076622021708)
      Iglesias P, Díez JJ (2009) Thyroid dysfunction and kidney disease. Eur J Endocrinol 160(4):503–515. https://doi.org/10.1530/eje-08-0837. (PMID: 10.1530/eje-08-083719095779)
      Yasuda T, Kaneto H, Kuroda A, Yamamoto T, Takahara M, Naka T, Miyashita K, Fujisawa K, Sakamoto F, Katakami N, Matsuoka TA, Shimomura I (2011) Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes. Diabetes Res Clin Pract 94(3):e75–e77. https://doi.org/10.1016/j.diabres.2011.08.019. (PMID: 10.1016/j.diabres.2011.08.01921925759)
      Toda A, Hara S, Tsuji H, Arase Y (2020) Subclinical hypothyroidism is associated with albuminuria in Japanese nondiabetic subjects. Endocrine 68(3):592–598. https://doi.org/10.1007/s12020-020-02220-9. (PMID: 10.1007/s12020-020-02220-932060688)
      Levy RP, Roess TJ (1956) Proteinuria and hypothyroidism. N Engl J Med 255(11):519–520. https://doi.org/10.1056/nejm195609132551108. (PMID: 10.1056/nejm19560913255110813358880)
      Laclaustra M, Moreno-Franco B, Lou-Bonafonte JM, Mateo-Gallego R, Casasnovas JA, Guallar-Castillon P, Cenarro A, Civeira F (2019) Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome. Diabetes Care 42(2):303–310. https://doi.org/10.2337/dc18-1410. (PMID: 10.2337/dc18-141030552134)
      Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C (2016) Update on NHANES dietary data: focus on collection, release, analytical considerations, and uses to inform public policy. Adv Nutr 7(1):121–134. https://doi.org/10.3945/an.115.009258. (PMID: 10.3945/an.115.009258267730204717880)
      Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA (2012) Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 18(6):988–1028. https://doi.org/10.4158/ep12280.Gl. (PMID: 10.4158/ep12280.Gl23246686)
      Cho YT, Chen CW, Chen MP, Hu JL, Su H, Shiea J, Wu WJ, Wu DC (2013) Diagnosis of albuminuria by tryptic digestion and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. Clin Chim Acta 42076–81. https://doi.org/10.1016/j.cca.2012.12.016.
      Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612. https://doi.org/10.7326/0003-4819-150-9-200905050-00006. (PMID: 10.7326/0003-4819-150-9-200905050-00006194148392763564)
      Zhang H, Che W, Shi K, Huang Y, Xu C, Fei M, Fan X, Zhang J, Hu X, Hu F, Qin S, Zhang X, Huang Q, Yu F (2022) FT4/FT3 ratio: a novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients. Front Endocrinol (Lausanne) 131021326. https://doi.org/10.3389/fendo.2022.1021326.
      Wang C, Han S, Li Y, Tong F, Li Z, Sun Z (2022) Value of FT3/FT4 ratio in prognosis of patients with heart failure: a propensity-matched study. Front Cardiovasc Med 9859608. https://doi.org/10.3389/fcvm.2022.859608.
      Raets L, Minschart C, Van den Bruel A, Van den Bogaert E, Van Crombrugge P, Moyson C, Verhaeghe J, Vandeginste S, Verlaenen H, Vercammen C, Maes T, Dufraimont E, Roggen N, De Block C, Jacquemyn Y, Mekahli F, De Clippel K, Loccufier A, Laenen A, Devlieger R, Mathieu C, Decallonne B, Benhalima K (2022) Higher thyroid fT3-to-fT4 ratio is associated with gestational diabetes mellitus and adverse pregnancy outcomes. J Clin Med 11(17). https://doi.org/10.3390/jcm11175016.
      Türker F, Oral A, Şahin T, Türker B, Koçak E, Ataoğlu HE, Ahbab S (2021) Does the FT3-to-FT4 ratio easily predict the progression of NAFLD and NASH cirrhosis? J Int Med Res 49(11):3000605211056841. https://doi.org/10.1177/03000605211056841. (PMID: 10.1177/0300060521105684134763561)
      Lang X, Li Y, Zhang D, Zhang Y, Wu N, Zhang Y (2022) FT3/FT4 ratio is correlated with all-cause mortality, cardiovascular mortality, and cardiovascular disease risk: NHANES 2007–2012. Front Endocrinol (Lausanne) 13964822. https://doi.org/10.3389/fendo.2022.964822.
      Liu B, Wang Z, Fu J, Guan H, Lyu Z, Wang W (2021) Sensitivity to thyroid hormones and risk of prediabetes: a cross-sectional study. Front Endocrinol (Lausanne) 12657114. https://doi.org/10.3389/fendo.2021.657114.
      Shi W, Song D, Chen D, Duan W, Zhang J (2023) The association of thyroid parameters with markers of chronic kidney disease in euthyroid patients with type 2 diabetes. Endocr J. https://doi.org/10.1507/endocrj.EJ22-0643. (PMID: 10.1507/endocrj.EJ22-064337981325)
      Yu L, Li Z, Yang R, Pan G, Cheng Q, He Y, Liu Y, Liu F, Ma M, Yang T, Wang Y, Su J, Zheng Y, Gao S, Xu Q, Li L, Yu C (2022) Impaired sensitivity to thyroid hormones is associated with elevated blood glucose in coronary heart disease. Front Endocrinol (Lausanne) 13895843. https://doi.org/10.3389/fendo.2022.895843.
      Ding X, Wang Y, Liu J, Wang G (2022) Impaired sensitivity to thyroid hormones is associated with elevated homocysteine levels in the euthyroid population. J Clin Endocrinol Metab 107(9):e3731–e3737. https://doi.org/10.1210/clinem/dgac371. (PMID: 10.1210/clinem/dgac37135708733)
      Mehran L, Delbari N, Amouzegar A, Hasheminia M, Tohidi M, Azizi F (2022) Reduced Sensitivity to thyroid hormone is associated with diabetes and hypertension. J Clin Endocrinol Metab 107(1):167–176. https://doi.org/10.1210/clinem/dgab646. (PMID: 10.1210/clinem/dgab64634480566)
      Han Z, Chen L, Peng H, Zheng H, Lin Y, Peng F, Fan Y, Xie X, Yang S, Wang Z, Yuan L, Wei X, Chen H (2023) The role of thyroid hormone in the renal immune microenvironment. Int Immunopharmacol 119110172. https://doi.org/10.1016/j.intimp.2023.110172.
    • Grant Information:
      KRY-YN2022017 the Guang Ren Foundation Research Project of Affiliated Hospital of Jiangsu University; STL2021006 the Suzhou Science and Technology Planning Project
    • Contributed Indexing:
      Keywords: Albuminuria; NHANES; Population-based study; Sensitivity to thyroid hormones; Thyroid feedback quantile-based index
    • Accession Number:
      0 (Thyroid Hormones)
      Q51BO43MG4 (Thyroxine)
      9002-71-5 (Thyrotropin)
      06LU7C9H1V (Triiodothyronine)
    • Publication Date:
      Date Created: 20240210 Date Completed: 20240702 Latest Revision: 20240702
    • Publication Date:
      20240703
    • Accession Number:
      10.1007/s42000-024-00533-2
    • Accession Number:
      38340288